Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with the Italian Medicines Agency (AIFA) for ...

Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds ...

Vertex Pharmaceuticals (VRTX) announced a reimbursement agreement with the Italian Medicines Agency for eligible transfusion-dependent beta ...

CRISPR Therapeutics (NASDAQ:CRSP) traded higher in the premarket on Thursday after J.P. Morgan initiated its coverage with an Overweight recommendation, noting how the company stands out in the gene ...

The revised figure excludes results from Qnity Electronics, which will be separated on November 1, and the Aramids unit, ...

Eli Lilly and Company, Vertex Pharmaceuticals Inc, Amgen Inc, abrdn Healthcare Opportunities Fund. Read 's Market Analysis on Investing.com ...

Major indices were in the green early on Thursday as traders rotated back into technology names following the Federal Reserve ...